26th week of 2019 patent applcation highlights part 27 |
Patent application number | Title | Published |
20190194223 | THIENO[3,2-d]PYRIMIDINE, FURO[3,2-d]PYRIMIDINE, AND PYRROLO[3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | 2019-06-27 |
20190194224 | BACTERIAL TOPOISOMERASE I INHIBITORS WITH ANTIBACTERIAL ACTIVITY | 2019-06-27 |
20190194225 | DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY | 2019-06-27 |
20190194226 | FUSED [1,2]IMIDAZO[4,5-C] RING COMPOUNDS SUBSTITUTED WITH GUANIDINO GROUPS | 2019-06-27 |
20190194227 | BMP POTENTIATORS | 2019-06-27 |
20190194228 | NEW 1,2,4-TRIAZOLO-[3,4-b]-1,3,4-THIADIAZOLE DERIVATIVES | 2019-06-27 |
20190194229 | METHOD FOR PRODUCING ALKYL-INDIUM COMPOUNDS AND THE USE THEREOF | 2019-06-27 |
20190194230 | PROCESS FOR THE PREPARATION OF CRISABOROLE | 2019-06-27 |
20190194231 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOOD | 2019-06-27 |
20190194232 | METAL-ORGANIC FRAMEWORK AND METHOD OF PRODUCING THE SAME | 2019-06-27 |
20190194233 | PHOSPHINIC VANADIUM COMPLEX, CATALYTIC SYSTEM COMPRISING SAID PHOSPHINIC VANADIUM COMPLEX AND PROCESS FOR THE (CO) POLYMERIZATION OF CONJUGATED DIENES | 2019-06-27 |
20190194234 | METAL COMPLEXES CONTAINING HETEROCYCLE SUBSTITUTED LIGANDS, AND ELECTROLUMINESCENT DEVICES AND FORMULATIONS CONTAINING THE COMPLEXES | 2019-06-27 |
20190194235 | METHOD FOR THE PRODUCTION OF TETRAKIS(TRIHYDROCARBYL PHOSPHANE)PALLADIUM(0) | 2019-06-27 |
20190194236 | Organometallic Antibiotics | 2019-06-27 |
20190194237 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | 2019-06-27 |
20190194238 | METHOD FOR SYNTHESIS OF MONOCYCLOPENTADIENYL COMPLEXES OF ZIRCONIUM AND HAFNIUM | 2019-06-27 |
20190194239 | METHODS OF PRODUCING OLIGOSACCHARIDES FOR USE AS PREBIOTICS | 2019-06-27 |
20190194240 | CRYSTALLIZATION OF STEVIOL GLYCOSIDES | 2019-06-27 |
20190194241 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEMENTIA AND IMPROVING COGNITIVE FUNCTION, COMPRISING GLASSWORT EXTRACT | 2019-06-27 |
20190194242 | PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF | 2019-06-27 |
20190194243 | METHODS OF TREATING AND PREVENTING GASTROINTESTINAL MOTILITY DISORDERS USING AMINOSTEROLS | 2019-06-27 |
20190194244 | METHODS OF PREVENTING DEPRESSION AND SYMPTOMS THEREOF USING AMINOSTEROLS | 2019-06-27 |
20190194245 | BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF | 2019-06-27 |
20190194246 | SOLID PHASE PEPTIDE SYNTHESIS | 2019-06-27 |
20190194247 | BONE PROTEIN EXTRACTION WITHOUT DEMINERALIZATION | 2019-06-27 |
20190194248 | Polypeptide Separation Methods | 2019-06-27 |
20190194249 | POLYPEPTIDE EXHIBITING AFFINITY TO ANTIBODIES FORMING NON-NATIVE THREE-DIMENSIONAL STRUCTURE | 2019-06-27 |
20190194250 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | 2019-06-27 |
20190194251 | SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS | 2019-06-27 |
20190194252 | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS | 2019-06-27 |
20190194253 | PEPTIDES AND COMPOSITIONS COMPRISING SAME AND USES THEREOF IN THE TREATMENT OF DISEASES | 2019-06-27 |
20190194254 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | 2019-06-27 |
20190194255 | COMPOSITIONS AND METHODS FOR MODULATING GAMMA-C-CYTOKINE ACTIVITY | 2019-06-27 |
20190194256 | SOLID STATE FORMS OF LINACLOTIDE | 2019-06-27 |
20190194257 | VASOPRESSIN-2 RECEPTOR AGONISTS | 2019-06-27 |
20190194258 | METHOD FOR CONTROLLING IMPURITY OF CYCLOSPORIN A EYE GEL | 2019-06-27 |
20190194259 | STABLE DRY POWDER COMPOSITION COMPRISING BIOLOGICALLY ACTIVE MICROORGANISMS AND/OR BIOACTIVE MATERIALS AND METHODS OF MAKING | 2019-06-27 |
20190194260 | LIVE ATTENUATED ZIKA VIRUS VACCINE | 2019-06-27 |
20190194261 | TETRAVALENT DENGUE VACCINE | 2019-06-27 |
20190194262 | ENGINEERED OUTER DOMAIN (EOD) OF HIV GP120 AND MUTANTS THEREOF | 2019-06-27 |
20190194263 | PREVENTION, TREATMENT AND DIAGNOSIS OF P.GINGIVALIS INFECTION | 2019-06-27 |
20190194264 | LIPOPROTEIN EXPORT SIGNALS AND USES THEREOF | 2019-06-27 |
20190194265 | COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS | 2019-06-27 |
20190194266 | PESTICIDAL GENES AND METHODS OF USE | 2019-06-27 |
20190194267 | MUCOADHESIVE MICROORGANISM | 2019-06-27 |
20190194268 | MULTIMERIC DEFENSIN PROTEINS AND RELATED METHODS | 2019-06-27 |
20190194269 | POLYNUCLEOTIDES AND POLYPEPTIDES USEFUL FOR MAKING ALKALOID COMPOUNDS | 2019-06-27 |
20190194270 | SPECIFIC ACTIVE SITE INHIBITORS OF ENZYMES OR SUBSTRATE BINDING PARTNERS AND METHODS OF PRODUCING SAME | 2019-06-27 |
20190194271 | FUSION PROTEINS FOR INHIBITING ANGIOGENESIS | 2019-06-27 |
20190194272 | RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOF | 2019-06-27 |
20190194273 | RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOF | 2019-06-27 |
20190194274 | RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOF | 2019-06-27 |
20190194275 | MENTSH ANALOGS AS THERAPEUTICS FOR DIABETES, OBESITY, AND THEIR ASSOCIATED DISEASES AND COMPLICATIONS | 2019-06-27 |
20190194276 | MATERIALS AND METHODS FOR TREATING CANCER | 2019-06-27 |
20190194277 | USE OF FCRN ANTAGONISTS FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS | 2019-06-27 |
20190194278 | NOVEL IMMUNOSTIMULATING PEPTIDES | 2019-06-27 |
20190194279 | Wound Healing Peptide | 2019-06-27 |
20190194280 | PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE | 2019-06-27 |
20190194281 | DELIVERY OF AN AGENT TO AUTOPHAGIC AND APOPTOTIC CELLS BY VESICLES WITH A PROTEIN EXPRESSED ON SURFACE THEREOF | 2019-06-27 |
20190194282 | CHIMERIC PROTEINS FOR TARGETING dsRNA | 2019-06-27 |
20190194283 | IMMUNOMODULATORY POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS | 2019-06-27 |
20190194284 | TARGETED MUTANT INTERFERON-BETA AND USES THEREOF | 2019-06-27 |
20190194285 | Novel Acylated Insulin Analogues and Uses Thereof | 2019-06-27 |
20190194286 | METHOD OF MANUFACTURING MEMBRANE PROTEIN AND UTILIZATION THEREOF | 2019-06-27 |
20190194287 | METHODS AND COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | 2019-06-27 |
20190194288 | CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES AND THEIR USE IN CANCER TREATMENT | 2019-06-27 |
20190194289 | UTERINE CANCER TREATMENTS | 2019-06-27 |
20190194290 | METHODS FOR PREVENTING, MODULATING AND/OR REDUCING CARDIOVASCULAR DISEASE | 2019-06-27 |
20190194291 | C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES | 2019-06-27 |
20190194292 | Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer | 2019-06-27 |
20190194293 | SOLUBLE INTERFERON RECEPTORS AND USES THEREOF | 2019-06-27 |
20190194294 | AGENT FOR RESTORING VISUAL FUNCTION OR AGENT FOR PREVENTING DETERIORATION IN VISUAL FUNCTION | 2019-06-27 |
20190194295 | VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA A | 2019-06-27 |
20190194296 | PEPTIDE COMPOUNDS FOR SUPPRESSING INFLAMMATION | 2019-06-27 |
20190194297 | PROCESS TO EXTRACT AND RECOVER KERATIN AND KERATIN ASSOCIATED PROTEIN FROM ANIMAL BODY PARTS | 2019-06-27 |
20190194298 | SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES | 2019-06-27 |
20190194299 | MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF | 2019-06-27 |
20190194300 | VARIANT ANTIBODIES THAT BIND AIP2 | 2019-06-27 |
20190194301 | IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING COTH | 2019-06-27 |
20190194302 | METHOD FOR THE PRODUCTION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | 2019-06-27 |
20190194303 | METHODS FOR MODIFYING HUMAN ANTIBODIES BY GLYCAN ENGINEERING | 2019-06-27 |
20190194304 | FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF | 2019-06-27 |
20190194305 | ANTIBODY BINDING A LINEAR EPITOPE OF HUMAN P53 AND DIAGNOSTIC APPLICATIONS THEREOF | 2019-06-27 |
20190194306 | COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF FUTRINS (R-SPONDINS) AND/OR WNT | 2019-06-27 |
20190194307 | SINGLE DOMAIN BINDING MOLECULE | 2019-06-27 |
20190194308 | ANTI-VEGF-A AND ANTI-ANG2 ANTIBODIES AND USES THEREOF | 2019-06-27 |
20190194309 | MACROPHAGE STIMULATING PROTEIN RECEPTOR (OR RON - RECEPTEUR D' ORIGINE NANTAIS) ANTIBODIES AND USES THEREOF | 2019-06-27 |
20190194310 | ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF | 2019-06-27 |
20190194311 | METHODS OF TREATING NEW-ONSET PLAQUE TYPE PSORIASIS USING IL-17 ANTAGONISTS | 2019-06-27 |
20190194312 | IL-6 ANTIBODIES | 2019-06-27 |
20190194313 | ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF CAPABLE OF BINDING TO A HUMAN RECEPTOR OF INTERLEUKIN-6 | 2019-06-27 |
20190194314 | ANTIBODIES FOR MODULATING BINDING BETWEEN LRP AND WISE | 2019-06-27 |
20190194315 | ANTIBODY DRUG CONJUGATES | 2019-06-27 |
20190194316 | ANTBODY FUSION PROTEIN AND RELATED COMPOSITIONS FOR TARGETING CANCER | 2019-06-27 |
20190194317 | HUMANIZED ANTI CLEVER-1 ANTIBODIES AND THEIR USE | 2019-06-27 |
20190194318 | Immunoconjugates with an Intracellularly-Cleavable Linkage | 2019-06-27 |
20190194319 | ANTI-ASCL1 ANTIBODIES AND METHODS OF USE | 2019-06-27 |
20190194320 | METHODS OF IDENTIFYING EPITOPES | 2019-06-27 |
20190194321 | ANTIBODIES THAT BIND AND BLOCK TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1 (TREM-1) | 2019-06-27 |
20190194322 | IDENTIFICATION OF VSIG3/VISTA AS A NOVEL IMMUNE CHECKPOINT AND USE THEREOF FOR IMMUNOTHERAPY | 2019-06-27 |